Eli Lilly Says FDA Expands Label For Zepbound To Include Four-Dose Single-Patient Use KwikPen

Feb 23 (Reuters) - Eli Lilly and Co LLY.N:

• ELI LILLY: FDA APPROVED LABEL EXPANSION FOR ZEPBOUND (TIRZEPATIDE) TO INCLUDE FOUR-DOSE SINGLE-PATIENT USE KWIKPEN

• ELI LILLY: ZEPBOUND PATIENTS CAN NOW ACCESS ALL DOSES IN EITHER MULTI-DOSE KWIKPEN OR SINGLE-DOSE VIAL STARTING AT $299 PER MONTH FOR 2.5 MG DOSE

• ELI LILLY: ZEPBOUND KWIKPEN IS AVAILABLE IN 2.5 MG, 5 MG, 7.5 MG, 10 MG, 12.5 MG, OR 15 MG DOSES